R Paoletti, G Franceschini, C R Sirtori. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Adipose Tissue/metabolismAnimalsApolipoprotein C-IIApolipoprotein C-IIIApolipoproteins/bloodApolipoproteins CBezafibrateCholesterol/bloodCholesterol, HDLClinical Trials as TopicClofibric Acid/analogs & derivativesClofibric Acid/pharmacologyFenofibrate/analogs & derivativesHumansHyperlipoproteinemia Type II/drug therapyHypolipidemic Agents/metabolismHypolipidemic Agents/therapeutic useLipolysis/drug effectsLipoproteins, HDL/bloodNiacinRatsStructure-Activity Relationship
Substances: See more » Apolipoprotein C-IIApolipoprotein C-IIIApolipoproteinsApolipoproteins CCholesterol, HDLHypolipidemic AgentsLipoproteins, HDLetofibrateNiacinClofibric AcidCholesterolfenofibric acidFenofibrateBezafibrate
Year: 1983 PMID: 6351577 DOI: 10.1016/0002-9149(83)90653-7
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778